Pulmonx Corp — Director's Dealing 2021

Sep 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2021-09-01

Reporting Person: Rose Geoffrey Beran (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-01	Common Stock	S	355	$40.09	Disposed	166814	Direct

Footnotes

F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.

F2: Includes 284 shares acquired by the reporting person under the Issuer's 2020 Employee Stock Purchase Plan on August 13, 2021.